Td Asset Management Inc Theseus Pharmaceuticals, Inc. Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023
BUY
$2.66 - $10.04 $284,481 - $1.07 Million
106,948 Added 100.0%
213,896 $575,000
Q2 2022

Aug 04, 2022
BUY
$5.04 - $14.05 $200,667 - $559,400
39,815 Added 59.31%
106,948 $591,000
Q1 2022

May 10, 2022
BUY
$8.75 - $14.51 $95,646 - $158,608
10,931 Added 19.45%
67,133 $774,000
Q4 2021

Feb 10, 2022
BUY
$8.98 - $20.09 $504,693 - $1.13 Million
56,202 New
56,202 $713,000

Others Institutions Holding THRX

# of Institutions
2
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Theseus Pharmaceuticals, Inc.

THRX Quotes by TradingView
  • Ticker THRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,713,400
  • Description
  • Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...
More about THRX
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email